Dan: Optimizing Care for Atopic Dermatitis - POCN
:Home>>Dan: Optimizing Care for Atopic Dermatitis

Dan: Optimizing Care for Atopic Dermatitis

Dermatology | December 23, 2020

Credits:

0.25 AANP Contact Hours
0.25 AMA PRA Category 1 Credit(s)™
Start Course

Launch Date:

December 23, 2020

Expiration Date:

December 22, 2021

primary audience:

Dermatologists, Nurse practitioners (nps), Pediatric dermatologists, Physician assistants (pas), Primary care physicians

Relevant Terms:

Atopic dermatitis, Comorbidities, Quality of life, Systemic therapy, Type 2 inflammation

course faculty

Brad P. Glick, DO, MPH, FAAD, FAOCD

Dr. Brad Glick is a board certified dermatologist and dermatologic surgeon with clinical and academic practices in South Florida. He is the Director of the Dermatology Residency at the Larkin Hospital, Palm Springs and Clinical Assistant Professor of Dermatology at the Herbert Wertheim College of Medicine Miami, Florida. Dr. Glick is also Director, and Principal Investigator for GSI Clinical Research in Margate, Florida as well as the current Vice President for the Florida Society for Dermatology and Dermatologic Surgery.

Dr. Glick’s Dermatology residency training was performed at the Greater Miami Skin and Laser Center at Mount Sinai Medical Center, Miami Beach, Florida where he earned certificates in Dermatologic, Mohs Micrographic, and Laser Surgery.

He is a Diplomate of the American Osteopathic Board of Dermatology, American Osteopathic Board of Family Practice, and National Board of Osteopathic Medical Examiners. Dr. Glick has also served as past President of the American Osteopathic College of Dermatology (AOCD), President of the Foundation for Osteopathic Dermatology (FOD), and past President of the Broward County Dermatologic Society.

Elizabeth Swanson, MD, FAAD

Dr. Swanson is a board-certified dermatologist and pediatric dermatologist. She was born in New Orleans, Louisiana, and raised in Scottsdale, Arizona. She attended college at the University of Colorado at Boulder, graduating with honors as an English major. After that she obtained her medical degree from Tulane University School of Medicine in New Orleans. She performed her internship at Mayo Clinic in Scottsdale, Arizona, and went on to complete her dermatology residency at Mayo Clinic in Rochester, Minnesota. After that, she completed a fellowship in Pediatric Dermatology at Phoenix Children’s Hospital in Arizona. She was in private practice in Colorado from 2011 through 2020. She moved to Boise, Idaho in summer 2020 to become the first and only pediatric dermatologist in the state of Idaho. 

She served as Treasurer, Vice President and President of the Colorado Dermatological Society. She was a member of the Legislative Council for the Colorado Medical Society from 2016 through 2020. She is an active lecturer at conferences discussing pediatric dermatology with audiences across the country. She has been selected as a “Top Doc” by 5280 Magazine every year from 2012 through 2020. She is on staff at St Luke’s Children’s Hospital where she sees hospital consults and performs procedures.

learning objectives
1. Implement effective strategies for comprehensively managing AD in children and adults.
course information

Program Overview

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense itching and recurrent eczematous lesions. The disease affects up to 20% of children and up to 3% of adults. AD usually starts in childhood, and may represent the cutaneous manifestation of an “atopic march” in which most patients also develop asthma and allergic rhinitis.

AD has a tremendous negative impact on the quality of life of both patients and their families. The disease is associated with several comorbidities, including mental health disorders (depression, anxiety, autism, ADHD), hypertension, obesity, infections, osteoporosis, fractures, vitiligo, alopecia areata, visual problems, and dental issues. Patients are more accident-prone and sleep disturbances are common which persist even during periods of remission.

This online curriculum will examine the clinical characteristics, the current understanding of immuno-pathophysiology, and the psychosocial and quality of life impact of AD on patients across age groups. Strategies to individualize treatment for patients with atopic dermatitis will be discussed.

 

 ACCME Accreditation Statement

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Credit Designation Statement

The National Association for Continuing Education designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

AANP Approval

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hour(s).

 

Disclosure of Commercial Support

This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

 

Course Directors

Brad P. Glick, DO, MPH, FAAD, FAOCD

Program Director, Dermatology Residency

Larkin Community Hospital Palm Springs

Deputy Chair, Individual Giving Committee, AAD

Vice President, Florida Society for Dermatology and Dermatologic Surgery

Clinical Assistant Professor of Dermatology

Herbert Wertheim College of Medicine

Miami, Florida

 

Elizabeth (Lisa) Swanson, MD

Ada West Dermatology

St Luke’s Children’s Hospital

Boise, ID

 

Medical Writer:

Joshua Kilbridge, Medical Writer

 

Disclosure of Unlabeled/Investigational Uses of Products

The content of the presentations may include discussion of unapproved or investigational uses of product or devices.

 

Policy on Faculty and Provider Disclosure

Educational programs sponsored by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a NACE-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Any potential conflicts of interest will be resolved prior to the activity.

 

Per the ACCME, a Commercial Interest is defined as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on, patients. Providers of clinical service directly to patients are not considered to be commercial interests – unless the provider of the clinical service is owned, or controlled by, a defined commercial interest.

 

Faculty disclosures are provided below:

 

Individual Disclosure Statements

Brad Glick, DO has disclosed the following financial relationships: :

  • Investigator: AbbVie, Celgene, ChemoCentryx, Dermira, and Sun Pharma.
  • Advisory Board Member: AbbVie, Celgene, Dermavant, Dermira, Genzyme, Lilly Novartis, Ortho Dermatologics, Pfizer, Sanofi, and Sun Pharma.
  • Speaker/Teaching: AbbVie, Celgene, Dermira, Lilly, Ortho Dermatologics, Novartis, Pfizer, and Sun Pharma.

Elizabeth (Lisa) Swanson, MD has disclosed the following financial relationships:

  • Advisory Board Member: Sanofi Regeneron, Janssen, Lilly, Ortho Dermatologics, Cassiopea
  • Speakers Bureau: Ortho Dermatologics, Pfizer, Amgen, Sanofi Regneron, Almirall, Janssen, Lilly
  • Speaking/Teaching: Ortho Dermatologics, Pfizer, Amgen, Sanofi Regneron, Almirall, Janssen, Lilly

 

Planning Committee

Gregg Sherman, MD, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

 

Laurl Ann Matey, MSN, RN, CHPN, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

 

Angela Golden, DNP, FNP-C, FAANP, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

 

Michelle Frisch, MPH, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

 

Sheila Lucas, CWEP, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

 

Joshua Kilbridge, Medical Writer, has no relevant conflicts of interest with any ACCME-defined commercial interest.

 

How to claim credit

1.          Read the learning objectives and faculty disclosures.

2.          Participate in the activity.

3.          Complete the post-test and activity evaluation.

4.          Physicians who successfully complete the post-test and evaluation will receive CME credit.

5.          Nurse Practitioners who successfully complete the post-test and evaluation will receive AANP CE credit.

6.          You must score 70% or higher on the post-test to receive credit for this activity.

7.          All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

 

Course format/medium: Internet CME Activity

Estimated time to complete the activity: 15 minutes

 

Supported Browsers:

Internet Explorer 8.0+ for Windows 2000, 2003,

Vista, XP, Windows 7, Windows 8 and above

Google Chrome 28.0+ for Windows, Mac OS, or

Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash

or Quicktime.

Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above

 

Go to Top